A significant increase in S100β intensity from AD-derived astrocytes was also observed relative to healthy controls (81.6 a.u ± 29.4 SD and 34.7 a.u ± 11.6 SD, respectively) (p < 0.01; Fig. 2F). This evidence concerns the gene S100B and Alzheimer disease.